These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1440532)

  • 41. Dextran sulfate inhibits E-selectin-mediated neutrophil adhesion to endotoxin-activated vascular endothelial cells.
    Matsumiya A; Yamaguchi M; Nakano H; Takeda M; Kumada K
    Life Sci; 1999; 64(2):PL9-17. PubMed ID: 10069494
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heparin promotes the inactivation of antithrombin by neutrophil elastase.
    Jordan RE; Kilpatrick J; Nelson RM
    Science; 1987 Aug; 237(4816):777-9. PubMed ID: 3649921
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endotoxin-induced pulmonary vascular injury is mainly mediated by activated neutrophils in rats.
    Uchiba M; Okajima K; Murakami K; Okabe H; Takatsuki K
    Thromb Res; 1995 Apr; 78(2):117-25. PubMed ID: 7482429
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Autoantibodies to heparin polysaccharides bind to vascular endothelial cells].
    Shibata S
    Rinsho Byori; 1998 Dec; 46(12):1205-9. PubMed ID: 9916505
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anticoagulant potential of endothelial cell membrane components.
    Preissner KT
    Haemostasis; 1988; 18(4-6):271-300. PubMed ID: 3069643
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human recombinant interleukin-1 beta- and tumor necrosis factor alpha-mediated suppression of heparin-like compounds on cultured porcine aortic endothelial cells.
    Kobayashi M; Shimada K; Ozawa T
    J Cell Physiol; 1990 Sep; 144(3):383-90. PubMed ID: 2202741
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antithrombin prevents endotoxin-induced pulmonary vascular injury by inhibiting leukocyte activation.
    Okajima K
    Blood Coagul Fibrinolysis; 1998 Apr; 9 Suppl 2():S25-37. PubMed ID: 9662467
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of endotoxin-induced endothelial function by calcium/calmodulin-dependent protein kinase.
    Cuschieri J; Gourlay D; Garcia I; Jelacic S; Maier RV
    Shock; 2003 Aug; 20(2):176-82. PubMed ID: 12865664
    [TBL] [Abstract][Full Text] [Related]  

  • 49. On the control of the plasma contact activation system on human endothelium: comparisons with heparin surface.
    Sánchez J; Olsson P
    Thromb Res; 1999 Jan; 93(1):27-34. PubMed ID: 10065896
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transendothelial migration of effector T cells across inflamed endothelial barriers does not require heparan sulfate proteoglycans.
    Stoler-Barak L; Barzilai S; Zauberman A; Alon R
    Int Immunol; 2014 Jun; 26(6):315-24. PubMed ID: 24402310
    [TBL] [Abstract][Full Text] [Related]  

  • 51. P-selectin mediates neutrophil rolling on histamine-stimulated endothelial cells.
    Jones DA; Abbassi O; McIntire LV; McEver RP; Smith CW
    Biophys J; 1993 Oct; 65(4):1560-9. PubMed ID: 7506064
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glycosaminoglycans increase levels of free and bioactive IGF-I in vitro.
    Møller AV; Jørgensen SP; Chen JW; Larnkjaer A; Ledet T; Flyvbjerg A; Frystyk J
    Eur J Endocrinol; 2006 Aug; 155(2):297-305. PubMed ID: 16868144
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of vascular human endothelial and rat smooth muscle cell growth by a fucosylated chondroitin sulfate from echinoderm.
    Tapon-Bretaudière J; Drouet B; Matou S; Mourão PA; Bros A; Letourneur D; Fischer AM
    Thromb Haemost; 2000 Aug; 84(2):332-7. PubMed ID: 10959709
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The modulation of heparin-like activity of endothelial cells in experimental systems.
    Shimada K; Kobayashi M; Ozawa T
    Nihon Ketsueki Gakkai Zasshi; 1989 Dec; 52(8):1337-42. PubMed ID: 2629459
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential effect of the low-molecular-weight heparin, dalteparin, and unfractionated heparin on microvascular endothelial cell hemostatic properties.
    Vignoli A; Marchetti M; Balducci D; Barbui T; Falanga A
    Haematologica; 2006 Feb; 91(2):207-14. PubMed ID: 16461305
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Additive thrombin inhibition by fast moving heparin and dermatan sulfate explains the anticoagulant effect of sulodexide, a natural mixture of glycosaminoglycans.
    Cosmi B; Cini M; Legnani C; Pancani C; Calanni F; Coccheri S
    Thromb Res; 2003 Mar; 109(5-6):333-9. PubMed ID: 12818259
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endotoxin and pulmonary cell injury.
    Bloom RJ; Simon LM; Benitz WE
    Surg Gynecol Obstet; 1988 Aug; 167(2):92-8. PubMed ID: 3041636
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The activities of some glycosaminoglycan-degrading enzymes in the wall of the umbilical cord artery and their alteration in edema, proteinuria, hypertension (EPH)-gestosis.
    Romanowicz L; Bańkowski E; Jaworski S
    Clin Chem Lab Med; 1999 Apr; 37(4):417-21. PubMed ID: 10369112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human platelet-derived transforming growth factor-beta stimulates synthesis of glycosaminoglycans in cultured porcine aortic endothelial cells.
    Kobayashi M; Shimada K; Ozawa T
    Gerontology; 1992; 38 Suppl 1():36-42. PubMed ID: 1459472
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Purification and biological property of heparin cofactor II: activation of heparin cofactor II and antithrombin III by dextran sulfate and various glycosaminoglycans.
    Yamagishi R; Niwa M; Kondo S; Sakuragawa N; Koide T
    Thromb Res; 1984 Dec; 36(6):633-42. PubMed ID: 6084876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.